Cargando…
Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
Management of metastatic or advanced prostate cancer has acquired several therapeutic approaches that have drastically changed the course of the disease. In particular due to the high sensitivity of prostate cancer cells to hormone depletion, several agents able to inhibit hormone production or bind...
Autores principales: | Mollica, Veronica, Di Nunno, Vincenzo, Cimadamore, Alessia, Lopez-Beltran, Antonio, Cheng, Liang, Santoni, Matteo, Scarpelli, Marina, Montironi, Rodolfo, Massari, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356740/ https://www.ncbi.nlm.nih.gov/pubmed/30642011 http://dx.doi.org/10.3390/cells8010043 |
Ejemplares similares
-
Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
por: Mollica, Veronica, et al.
Publicado: (2021) -
The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019) -
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
por: Di Nunno, Vincenzo, et al.
Publicado: (2018) -
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
por: Mollica, Veronica, et al.
Publicado: (2019) -
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020)